Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 34, 2012 - Issue 5
Submit an article Journal homepage
607
Views
16
CrossRef citations to date
0
Altmetric
Review Article

Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practice

Roberto CastelliDepartment of Internal Medicine, University of Milan, and Department of Medicine, IRCCS Ca’ Granda Policlinico, Milan, ItalyCorrespondence[email protected]
,
Antonino CannavòDepartment of Internal Medicine, University of Milan, and Department of Medicine, IRCCS Ca’ Granda Policlinico, Milan, Italy
,
Fabio ConfortiDepartment of Internal Medicine, University of Milan, and Department of Medicine, IRCCS Ca’ Granda Policlinico, Milan, Italy
,
Giovanni GravaDepartment of Internal Medicine, University of Milan, and Department of Medicine, IRCCS Ca’ Granda Policlinico, Milan, Italy
&
Agostino CortelezziHematology-Bone Marrow Transplant Unit, Department of Biomedical Sciences, University of Milan, IRCCS Ca’ Granda Policlinico, Milan, Italy
Pages 740-753 | Received 30 Dec 2011, Accepted 16 Jan 2012, Published online: 09 Mar 2012

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Hakan Parlakpinar & Mehmet Gunata. (2021) Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs. Immunopharmacology and Immunotoxicology 43:6, pages 651-665.
Read now
Anna Guidetti, Claudia Paba Prada, Jacob P Laubach, Cindy Varga, Michelle E Maglio, Mary McKenney, Deborah Doss, Robert L Schlossman, Constantine Mitsiades, Teru Hideshima, Güllü T Görgün, Irene M Ghobrial, Noopur Raje, Nikhil Munshi, Kenneth C Anderson & Paul G Richardson. (2014) Pomalidomide for the treatment of relapsed and refractory multiple myeloma. Expert Opinion on Orphan Drugs 2:10, pages 1089-1108.
Read now
Annalisa Patrizi, Michela Venturi, Emi Dika, Howard Maibach, Paola Tacchetti & Giovanni Brandi. (2014) Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects. Cutaneous and Ocular Toxicology 33:1, pages 1-6.
Read now
Roberto Castelli, Nicola Orofino, Agnese Losurdo, Roberta Gualtierotti & Massimo Cugno. (2014) Choosing treatment options for patients with relapsed/refractory multiple myeloma. Expert Review of Anticancer Therapy 14:2, pages 199-215.
Read now
Francesca Gay, Roberto Mina, Rossella Troia & Sara Bringhen. (2013) Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma. Expert Opinion on Drug Metabolism & Toxicology 9:11, pages 1517-1527.
Read now

Articles from other publishers (11)

Yumin Li, Cong He, Rui Liu, Zhongdang Xiao & Bo Sun. (2023) Stem cells therapy for diabetes: from past to future. Cytotherapy 25:11, pages 1125-1138.
Crossref
Kamila Szumilas, Aleksandra Wilk, Piotr Wiśniewski, Anna Gimpel, Violetta Dziedziejko, Markus Kipp & Andrzej Pawlik. (2023) Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation. International Journal of Molecular Sciences 24:12, pages 10301.
Crossref
Antonio Gidaro, Roberto Manetti, Alessandro Delitala, Mark Soloski, Giorgio Lambertenghi Deliliers, Dante Castro, Davide Soldini & Roberto Castelli. (2022) Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release. Journal of Clinical Medicine 11:10, pages 2720.
Crossref
Shuo Li, Xiang-Yu Meng, Souraka Tapara Dramani Maman, Yong-Nong Xiao & Sheng Li. (2018) Lenalidomide and Low Dose Dexamethasone Plus Elotuzumab or Carfilzomib for Relapsed or Refractory Multiple Myeloma: A Comparison of Progression-Free Survival with Reconstructed Individual Participant Data. BioMed Research International 2018, pages 1-6.
Crossref
Louis Royer-Perron, Khê Hoang-Xuan & Agusti Alentorn. (2017) Primary central nervous system lymphoma: time for diagnostic biomarkers and biotherapies?. Current Opinion in Neurology 30:6, pages 669-676.
Crossref
Massimo Giuliani, Bassam Janji & Guy Berchem. (2017) Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progression. Oncotarget 8:14, pages 24031-24044.
Crossref
Riccardo Colombo, Paolo Gallipoli & Roberto Castelli. (2014) Thrombosis and Hemostatic Abnormalities in Hematological Malignancies. Clinical Lymphoma Myeloma and Leukemia 14:6, pages 441-450.
Crossref
Xavier Leleu. (2013) New hope for relapsed and refractory multiple myeloma. The Lancet Oncology 14:11, pages 1028-1029.
Crossref
Roberto Castelli, Ramona Cassin, Antonino Cannavò & Massimo Cugno. (2013) Immunomodulatory Drugs: New Options for the Treatment of Myelodysplastic Syndromes. Clinical Lymphoma Myeloma and Leukemia 13:1, pages 1-7.
Crossref
Roberto CastelliRoberta GualtierottiNicola OrofinoAgnese LosurdoSara GandolfiMassimo Cugno. (2013) Current and Emerging Treatment Options for Patients with Relapsed Myeloma. Clinical Medicine Insights: Oncology 7, pages CMO.S8014.
Crossref
Robert S. Svatek & Tyler J. Curiel. 2013. Cancer Immunotherapy. Cancer Immunotherapy 399 424 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.